Success Metrics

Clinical Success Rate
88.9%

Based on 8 completed trials

Completion Rate
89%(8/9)
Active Trials
2(15%)
Results Posted
63%(5 trials)
Terminated
1(8%)

Phase Distribution

Ph phase_1
1
8%
Ph phase_4
1
8%
Ph phase_2
10
77%
Ph early_phase_1
1
8%

Phase Distribution

2

Early Stage

10

Mid Stage

1

Late Stage

Phase Distribution13 total trials
Early Phase 1First-in-human
1(7.7%)
Phase 1Safety & dosage
1(7.7%)
Phase 2Efficacy & side effects
10(76.9%)
Phase 4Post-market surveillance
1(7.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

2

trials recruiting

Total Trials

13

all time

Status Distribution
Active(2)
Completed(8)
Terminated(1)
Other(2)

Detailed Status

Completed8
Recruiting2
Terminated1
Suspended1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
2
Success Rate
88.9%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (7.7%)
Phase 11 (7.7%)
Phase 210 (76.9%)
Phase 41 (7.7%)

Trials by Status

terminated18%
suspended18%
unknown18%
completed862%
recruiting215%

Recent Activity

2 active trials
Showing 5 of 13
recruitingphase_2

Pyridostigmine for the Treatment of Constipation in Parkinson Disease

NCT05603715
recruitingphase_2

Pyridostigmine Efficacy and Safety for Treatment of Ileus After Colorectal Surgery

NCT05334485
completedphase_2

The Effects of Normalizing Blood Pressure on Cerebral Blood Flow in Hypotensive Individuals With Spinal Cord Injury

NCT02893553
completedphase_2

Safety and Efficacy Study of Pyridostigmine on Patients With Spinal Muscular Atrophy Type 3

NCT02227823
completedphase_2

The Exercise Response to Pharmacologic Cholinergic Stimulation in Myalgic Encephalomyelitis / Chronic Fatigue Syndrome

NCT03674541
View all 13 trials

Clinical Trials (13)

Showing 13 of 13 trials
NCT05603715Phase 2

Pyridostigmine for the Treatment of Constipation in Parkinson Disease

Recruiting
NCT05334485Phase 2

Pyridostigmine Efficacy and Safety for Treatment of Ileus After Colorectal Surgery

Recruiting
NCT02893553Phase 2

The Effects of Normalizing Blood Pressure on Cerebral Blood Flow in Hypotensive Individuals With Spinal Cord Injury

Completed
NCT02227823Phase 2

Safety and Efficacy Study of Pyridostigmine on Patients With Spinal Muscular Atrophy Type 3

Completed
NCT03674541Phase 2

The Exercise Response to Pharmacologic Cholinergic Stimulation in Myalgic Encephalomyelitis / Chronic Fatigue Syndrome

Completed
NCT02308124Phase 4

Treatment and Prognosis of Neurogenic Orthostatic Hypotension : A Prospective Randomized Study

Completed
NCT01993680Phase 2

Orthostatic Dysregulation and Associated Gastrointestinal Dysfunction in Parkinson's Disease -Treatment

Completed
NCT04343963Phase 2

Pyridostigmine in Severe SARS-CoV-2 Infection

Unknown
NCT03312244Phase 2

Pyridostigmine as Immunomodulator in People Living With HIV

Suspended
NCT02357225Early Phase 1

A Pilot Study of Pyridostigmine in Pompe Disease

Terminated
NCT01415921Phase 2

Safety Study of Pyridostigmine in Heart Failure

Completed
NCT02307526Phase 2

Acetylcholinesterase Inhibition and Orthostatic Hypotension in SCI

Completed
NCT00223691Phase 1

Treatment of Orthostatic Hypotension in Autonomic Failure

Completed

All 13 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
13